Back to Feed
Fintech▲ 50
Allucent expands leadership for CRO
Prnewswire·
Allucent, a specialized Contract Research Organization (CRO) for small and mid-sized biopharma companies, has expanded its strategic leadership team. The move aims to advance its Centers of Expertise and fortify its position as a leading specialty CRO. By bringing in new therapeutic strategy leaders, Allucent intends to enhance its service offerings and better support the complex needs of its biopharmaceutical clients in drug development.
Tags
healthtech
leadership
clinical trial
Original Source
Prnewswire — www.prnewswire.com